Renal Impairment Has No Relevant Effect on Long-Term Exposure of Linagliptin in Patients with Type 2 Diabetes Mellitus

被引：0
|
作者：
Friedrich, Christian
Emser, Angela
Woerle, Hans J.
Graefe-Mody, Ulrike
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1105-P
引用
收藏
页码：A303 / A304
页数：2
相关论文
共 50 条
  • [11] Vildagliptin in patients with type 2 diabetes mellitus and renal impairment
    Groop, Per-Henrik
    Dongre, Neelesh
    Kothny, Wolfgang
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 (02) : E12 - E13
  • [12] Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes mellitus and renal impairment - the FIELD study
    Ting, R.
    Donoghoe, M.
    Jenkins, A. J.
    Hedley, J.
    Rajamani, K.
    Drury, P. L.
    Davis, T. M. E.
    Celermajer, D.
    Simes, R. J.
    Keech, A. C.
    EUROPEAN HEART JOURNAL, 2011, 32 : 323 - 324
  • [13] Management of patients with type 2 diabetes and mild/moderate renal impairment: profile of linagliptin
    Gallwitz, Baptist
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 799 - 805
  • [14] Long-Term Exposure to Air Pollution and Type 2 Diabetes Mellitus in a Multiethnic Cohort
    Park, Sung Kyun
    Adar, Sara D.
    O'Neill, Marie S.
    Auchincloss, Amy H.
    Szpiro, Adam
    Bertoni, Alain G.
    Navas-Acien, Ana
    Kaufman, Joel D.
    Diez-Roux, Ana V.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2015, 181 (05) : 327 - 336
  • [15] Long-term prevention of impairment in renal function in patients with insulin-treated diabetes mellitus.
    Franke, S
    Appel, T
    Müller, UA
    Stein, G
    Schiel, R
    DIABETOLOGIA, 2003, 46 : A337 - A338
  • [16] Predictors of long-term cardiovascular outcomes in patients with type 2 diabetes mellitus
    Bianco, H.
    Helfenstein, T.
    Izar, M. C.
    Fonseca, H. A.
    Fischer, S. C.
    Ferreira, C. E.
    Xavier, H. T.
    Povoa, R. M.
    Fonseca, F. A.
    EUROPEAN HEART JOURNAL, 2012, 33 : 893 - 893
  • [17] Long-term effects of multifactorial intervention in patients with type 2 diabetes mellitus
    Jecht, M.
    DIABETOLOGE, 2016, 12 (08): : 580 - 581
  • [18] A randomized, double-blind, placebo-controlled study on long-term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the Long-Term ASP1941 Safety Evaluation in Patients with Type 2 Diabetes with Renal Impairment (LANTERN) study
    Kashiwagi, A.
    Takahashi, H.
    Ishikawa, H.
    Yoshida, S.
    Kazuta, K.
    Utsuno, A.
    Ueyama, E.
    DIABETES OBESITY & METABOLISM, 2015, 17 (02): : 152 - 160
  • [19] Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study
    Fumiko Yamamoto
    Rie Ikeda
    Kaori Ochiai
    Tetsuaki Hirase
    Naoyuki Hayashi
    Tomoo Okamura
    Diabetes Therapy, 2020, 11 : 523 - 533
  • [20] Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study
    Yamamoto, Fumiko
    Ikeda, Rie
    Ochiai, Kaori
    Hirase, Tetsuaki
    Hayashi, Naoyuki
    Okamura, Tomoo
    DIABETES THERAPY, 2020, 11 (02) : 523 - 533
12345